Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
Otsuka and Lundbeck get FDA nod for schizophrenia, bipolar disorder injection
3 years ago
Prescription refills help fuel telehealth's staying power as pandemic wanes
3 years ago
Marketing
Roche, Pfizer and Gilead lead reputation rankings by patient groups in annual survey
3 years ago
Marketing
Updated: FDA approves Pfizer’s Prevnar 20 for infants and children
3 years ago
FDA to review Takeda's BLA resubmission for subcutaneous UC drug Entyvio after 2019 rejection
3 years ago
Eli Lilly will use a priority review voucher on Mounjaro to 'remove any uncertainty' around fast FDA review
3 years ago
Updated: AbbVie axes two candidates as company revenue drops nearly 10%
3 years ago
Amid bankruptcy, Akorn is pulling dozens of generic products off the shelves
3 years ago
Manufacturing
Ahead of adcomm, FDA raises concerns about plan to expand Lynparza's use in prostate cancer
3 years ago
FDA+
GSK's new RSV campaign lands in advance of FDA decision set for next week
3 years ago
Marketing
Bristol Myers snaps up former Novartis manufacturing site in Illinois
3 years ago
Manufacturing
Roche's portfolio 'rejuvenation' fuels 9% increase in drug sales, led by eye treatment
3 years ago
Biogen CEO in search for 'external growth' to boost pipeline as revenue falls
3 years ago
R&D
J&J's consumer health spinout Kenvue lines up a $3B+ IPO, biggest health offering since 2018
3 years ago
Financing
Enanta sells off over 50% of royalty payments from Mavyret in exchange for $200M
3 years ago
Deals
Florida sues FDA again over Canadian drug import plan
3 years ago
FDA+
Law
FDA approves Biogen’s ALS drug tofersen, paving new road for accelerated pathway in neuro diseases
3 years ago
FDA+
How clinical trial advertising went from old-school tactics to splashy strategies to compete in a fierce market
3 years ago
Marketing
Bipartisan Senate legislation to reform PBMs, improve FDA processes kicks off with a markup next week
3 years ago
Law
Ferring builds out partnerships, taps social media to amplify fertility conversations
3 years ago
Marketing
Samsung Biologics to expand manufacturing in South Korea; WuXi AppTec expects up to 7% revenue growth this year
3 years ago
Manufacturing
BioMarin makes $41M+ expansion to Irish facility
3 years ago
Manufacturing
European pharma overhaul draft is coming Wednesday: Here's what's expected
3 years ago
Law
Boehringer Ingelheim kicks off €350M R&D center in Germany
3 years ago
R&D
First page
Previous page
130
131
132
133
134
135
136
Next page
Last page